OCUGEN, INC. Prepaid Expense and Other Assets, Current
OCUGEN, INC. (OCGN) had Prepaid Expense and Other Assets, Current of $6.67 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $6.67M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $6.70M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $5.77M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $5.07M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.67M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $6.70M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $5.77M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $5.07M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $5.87M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $6.16M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $3.17M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $1.98M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.92M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.62M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.51M 10-K · filed 2025-03-05 | |
| 2023-09-30 | $3.08M 10-K · filed 2024-04-16 | |
| 2023-06-30 | $2.87M 10-K · filed 2024-04-16 | |
| 2023-03-31 | $7.68M 10-K · filed 2024-04-16 | |
| 2022-12-31 | $7.56M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $5.89M 10-K · filed 2024-04-16 | |
| 2022-06-30 | $7.56M 10-K · filed 2024-04-16 | |
| 2022-03-31 | $8.26M 10-K · filed 2024-04-16 | |
| 2021-12-31 | $7.69M 10-K · filed 2023-02-28 | $2.70M 10-K · filed 2022-02-28 |
| 2021-09-30 | $1.11M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $996.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $1.58M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $1.84M 10-K · filed 2022-02-28 | $1.84M 10-K · filed 2021-03-19 |
| 2020-09-30 | $652.89K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $924.50K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.17M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $1.32M 10-K · filed 2021-03-19 | |
| 2019-09-30 | $517.56K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $498.64K 8-K/A · filed 2019-10-07 | $414.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $764.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $313.50K 10-K · filed 2020-03-27 | $858.00K 10-K · filed 2019-03-22 |
| 2018-09-30 | $825.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $881.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $858.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $194.00K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $258.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $304.00K 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $296.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $173.00K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $201.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $350.00K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $466.00K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $321.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $365.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $897.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $829.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $796.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |